Indian markets present attractive long-term investment opportunities following recent corrections, according to Nitin Raheja of Julius Baer...

Infosys closed FY26 with strong numbers aided by ⁠a pickup ⁠in demand from its banking, energy and communication segments. This and more in...

Smallcap valuations seem high but underlying fundamentals have improved. Aditya Khemani of Invesco Mutual Fund sees this as a structural sh...

Laurus Labs shares fell despite Q2FY26 PAT surging 886% to Rs 195 crore, revenue rising 35%, and EBITDA more than doubling, with margins ex...

And, of course, the chemical in terms of the domain expertise, the kind of the chemistry skills and the overall talent pool that this count...

Akums Drugs and Pharmaceuticals' shares began trading at Rs 725, a 6.8% premium over the issue price of Rs 679, after an IPO that was subsc...

Akums Drugs and Pharmaceuticals will debut on Tuesday. The stock, with a GMP of Rs 140, is expected to list at a 21% premium over the upper...

"We want to be a diversified, end-to-end capability outsourcing partner, serving customers from development to commercial scale. Doing this...

The IPO of Blue Jet Healthcare was booked nearly 8 times at close, led by healthy interest from NIIs and QIBs. The IPO was priced in the ra...

According to market analysts, Blue Jet Healthcare's shares are fetching a premium of Rs 22 in the unlisted market. Most analysts have a 'su...

Most analysts have a subscription recommendation on the IPO, which is entirely an offer for the sale of 2.42 crore shares. Under the OFS, p...

The US-based PE firm which is betting on India pharma, said that it intends to add more assets in the future with the vision to become one ...

Jefferies has initiated coverage on Gland Pharma and Laurus Labs with buy ratings as it believes that Indian contract development and manuf...

The company has already decided to allocate 26,18,706 equity shares at Rs 460 apiece to 22 funds aggregating to Rs 120.46 crore, according ...

Windlas Biotech has already decided to allocate 26,18,706 equity shares at Rs 460 apiece to 22 funds aggregating to Rs 120.46 crore, accord...

The Rs 401 crore issue received applications for 63,38,730 shares out of on-offer 61,36,252 shares, meaning a subscription of slightly over...

The Dehradun-based firm will raise Rs 165 crore through issuance of fresh equity shares, while the promoters and existing shareholders will...